Y. Matsunaga

发表

Activation of Antigen-Specific Cytotoxic T Lymphocytes by β2-Microglobulin or TAP1 Gene Disruption and the Introduction of Recipient-Matched MHC Class I Gene in Allogeneic Embryonic Stem Cell-Derived Dendritic Cells1

S. Senju, Y. Nishimura, S. Fukushima, 2008, The Journal of Immunology.

Pharmacokinetics of Amrubicin and Its Active Metabolite Amrubicinol in Lung Cancer Patients

I. Okamoto, J. Sasaki, M. Matsumoto, 2006, Therapeutic drug monitoring.

Multiple Antigen-targeted Immunotherapy With α-Galactosylceramide–loaded and Genetically Engineered Dendritic Cells Derived From Embryonic Stem Cells

S. Senju, Y. Nishimura, S. Fukushima, 2009, Journal of immunotherapy.

Application of iPS cell-derived macrophages to cancer therapy

S. Senju, Y. Nishimura, M. Haruta, 2014, Oncoimmunology.

Phase I and pharmacokinetic study of amrubicin, a synthetic 9-aminoanthracycline, in patients with refractory or relapsed lung cancer

I. Okamoto, J. Sasaki, A. Hamada, 2006, Cancer Chemotherapy and Pharmacology.

Pluripotent stem cell-derived dendritic cells for immunotherapy.

S. Senju, Y. Nishimura, S. Fukushima, 2010, Frontiers in bioscience.

Genetically Manipulated Human Embryonic Stem Cell‐Derived Dendritic Cells with Immune Regulatory Function

Yusuke Nakamura, T. Katagiri, S. Senju, 2007, Stem cells.

Regulation of macrophage-like cell activity driven by atmospheric oxygen plasma

N. Hayashi, Y. Matsunaga, Yixin Yao, 2020, Japanese Journal of Applied Physics.

Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy

S. Senju, Y. Nishimura, S. Fukushima, 2011, Gene Therapy.

Characterization of Dendritic Cells and Macrophages Generated by Directed Differentiation from Mouse Induced Pluripotent Stem Cells

Yusuke Matsunaga, Shinya Yamanaka, Yasuharu Nishimura, 2009, Stem cells.

Performance of a conventional enzyme immunoassay for hepatitis C virus core antigen in the early phases of hepatitis C infection.

S. Yagi, E. Tanaka, K. Aoyagi, 2001, Clinical laboratory.

Therapeutic Effect of Human iPS-Cell–Derived Myeloid Cells Expressing IFN-β against Peritoneally Disseminated Cancer in Xenograft Models

S. Senju, Y. Nishimura, M. Haruta, 2013, PloS one.

Immunotherapy with pluripotent stem cell-derived dendritic cells

S. Senju, Y. Nishimura, S. Fukushima, 2011, Seminars in Immunopathology.

Dual Effects of TRAIL in Suppression of Autoimmunity: The Inhibition of Th1 Cells and the Promotion of Regulatory T Cells

S. Senju, Y. Nishimura, Takaaki Ito, 2010, The Journal of Immunology.

Pluripotent stem cells as source of dendritic cells for immune therapy

S. Senju, Y. Nishimura, S. Fukushima, 2010, International journal of hematology.